510(k) Report

510(k) · Cleared

Cleared

Solarc / Solrx E-Series Ultraviolet Phototherapy Lamp Unit Family

K103204510(k) TraditionalCleared Apr 27, 2011177-day reviewClass II21 CFR 878.4630

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Solarc Systems, Inc. · FTC Light, Ultraviolet, Dermatological

Cleared on Apr 27, 2011 as substantially equivalent to K935572 (Solarc Systems, Inc., 1994) and 4 other predicates after a 177-day review. Its family tree reaches back 1 generation to 1982.

Decided
Apr 27, 2011
Review
177 days
Class
Class II
Product code
FTC
Recalls
None
Predicates
5

Its longest line of descent runs back 1 generation to K827890 (1982). 5 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2006: 1 other ancestor2003: 1 other ancestor1994: 1 other ancestor1985: 1 other ancestorK827890 · Foldalite Unit · National Biological Corp. · 19821980198519901995200020052010
Other ancestors, by generation 1 generation back: 4 other ancestors K827890 · Foldalite Unit · National Biological Corp. · 19820
  1. Root · 1 generation backK827890 Foldalite UnitNational Biological Corp. · 1982
  2. This deviceK103204 Solarc / Solrx E-Series Ultraviolet Phototherapy Lamp Unit FamilySolarc Systems, Inc. · 2011
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K827890Foldalite UnitNational Biological Corp.1982—
0 (this device)K103204Solarc / Solrx E-Series Ultraviolet Phototherapy Lamp Unit FamilySolarc Systems, Inc.2011—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198510
199410
200310
200610
FIG. 1 — Lineage of K103204, 1982–2011Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FTC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FTC device

  1. #1 K242977 308nm Excimer Phototherapy Device (CN-308E…score 14.8 · 21 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (7)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K935572Solarc 1000 Series Ultraviolet Phototherapy Lamp Unit
Summary page 1
…the proposed device family has the same intended use and similar technical characteristics as the following predicate devices: Solarc/SolRx 1000 Series [51 0(k)# K935572] Solarc/SoIRx 500 Series [510(k)# K031800] Solarc/SolRx 100 Series [51 0(k)#: K061589] Daavlin "7-Series" an…
Solarc Systems, Inc.1994—
*K031800Solarc/Solrx 500 Series Ultraviolet Phototherapy Lamp Unit Family a New Medical Device…
Summary page 1
…use and similar technical characteristics as the following predicate devices: Solarc/SolRx 1000 Series [51 0(k)# K935572] Solarc/SoIRx 500 Series [510(k)# K031800] Solarc/SolRx 100 Series [51 0(k)#: K061589] Daavlin "7-Series" and "2-Series" [510(k)# K854498 "Spectra 724"]…
Solarc Systems, Inc.2003—
*K061589Solarc / Solrx Handheld Ultraviolet Phototherapy Lamp Unit Family
Summary page 1
…ollowing predicate devices: Solarc/SolRx 1000 Series [51 0(k)# K935572] Solarc/SoIRx 500 Series [510(k)# K031800] Solarc/SolRx 100 Series [51 0(k)#: K061589] Daavlin "7-Series" and "2-Series" [510(k)# K854498 "Spectra 724"] National Biological Corp. (NBC) "Foldalite-32" […
Solarc Systems, Inc.2006—
*K854498Spectra 724
Summary page 1
…[51 0(k)# K935572] Solarc/SoIRx 500 Series [510(k)# K031800] Solarc/SolRx 100 Series [51 0(k)#: K061589] Daavlin "7-Series" and "2-Series" [510(k)# K854498 "Spectra 724"] National Biological Corp. (NBC) "Foldalite-32" [510(k)#: K827890] National Biological Corp. (NBC) "P…
Daavlin Co.1985—
*K827890Foldalite Unit
Summary page 1
…x 100 Series [51 0(k)#: K061589] Daavlin "7-Series" and "2-Series" [510(k)# K854498 "Spectra 724"] National Biological Corp. (NBC) "Foldalite-32" [510(k)#: K827890] National Biological Corp. (NBC) "Panosol 3D" [510(k)#: uncertain] National Biological Corp. "Panosol 11... with op…
National Biological Corp.1982—
*—National Biological Corp. (NBC) "Panosol 3D"
Named without a submission number
—
*—National Biological Corp. "Panosol 11... with optional wings"
Named without a submission number
—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 5 ancestors has a recall.

How does its category compare?

All FTC devices

FTC Light, Ultraviolet, Dermatological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · FTC

3in 2025

2007: 42008: 32009: 22010: 12011: 52012: 12013: 12014: 22015: 32016: 12017: 22018: 32019: 22020: 52021: 32022: 12023: 42024: 12025: 32026 (partial year): 4
2007high 5 (2011) · low 1 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FTC

76in 2025

2007: 53 days median2008: 41 days median2011: 125 days median2015: 98 days median2018: 88 days median2020: 237 days median2021: 89 days median2023: 48 days median2025: 76 days median2026 (partial year): 91 days median
2007high 237 (2020) · low 41 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FTC

3so far in 2026, the most since 2007

2008: 12025: 12026 (partial year): 3
2007high 3 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FTC

8in 2025

2010: 22012: 12013: 12014: 12015: 82016: 22017: 22019: 142020: 42021: 482022: 42023: 52024: 42025: 8
2007high 48 (2021) · low 0 (2007)2025

MAUDE reports naming product code FTC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200745300
200834110
20092—00
20101—02
2011512500
20121—01
20131—01
20142—01
201539808
20161—02
20172—02
201838800
20192—014
2020523704
2021389048
20221—04
202344805
20241—04
202537618
20264913—

What is it indicated for?

The Solarc/SoIRx E-Series Ultraviolet Phototherapy Lamp Family is a wall-mounted or self-supporting ultraviolet phototherapy lamp unit used for the treatment of psoriasis, vitiligo, and atopic dermatitis (eczema). It is intended for use as a spot or full-body treatment device. It is intended for use on all skin types. (I -VI)

This device is intended for Prescriptive Use only, per Part 21 CFR 801 Subpart 0.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K103204: Solarc / Solrx E-Series Ultraviolet Phototherapy Lamp Unit Family.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K103204

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026